Technical Description
The invention involves a biocompatible glucose-responsive injectable non-polymeric hydrogel for highly efficient drug delivery under hyperglycemia.
Problems Addressed
- Poor Mechanical Strength
- Weak Stability
- Lack of Cell Adhesion
- Prone to Degradation
Tech Features
- Non-polymeric Hydrogel
- Injectable G-quartet
- Efficient Drug Delivery
- Sustained Release
- Supramolecular Assembly
- Non-toxic Formulation
Target Audience
- Pharmaceutical Industry
- Diagnostic Centers
- Healthcare Sector
- Diabetes Care Units
Tech ID: P35-2053 TRL 5 Patent Status: Published Available For Exclusive and Non-exclusive License
